We are live on
!
Find out more
Anavex Life Sciences
AVXL
AVXL
140 hedge funds and large institutions have $113M invested in Anavex Life Sciences in 2024 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 42 increasing their positions, 42 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
22% more call options, than puts
Call options by funds: $4.18M | Put options by funds: $3.44M
0% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 42
5% less funds holding
Funds holding: 147 → 140 (-7)
7.13% less ownership
Funds ownership: 38.81% → 31.67% (-7.1%)
22% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 27
30% less capital invested
Capital invested by funds: $161M → $113M (-$48.1M)
Holders
140
Holders Change
-7
Holders Change %
-4.76%
% of All Funds
2.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
42
Reduced
42
Closed
27
Calls
$4.18M
Puts
$3.44M
Net Calls
+$745K
Net Calls Change
+$658K
Top Buyers
| 1 |
Two Sigma Advisers
New York
|
+$2.36M |
| 2 |
Two Sigma Investments
New York
|
+$1.93M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$1.81M |
| 4 |
Renaissance Technologies
New York
|
+$1.56M |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$809K |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$14.4M |
| 2 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
-$4.1M |
| 3 |
NL
NWAM LLC
Mercer Island,
Washington
|
-$3.21M |
| 4 |
Citigroup
New York
|
-$2.1M |
| 5 |
Rafferty Asset Management
New York
|
-$1.8M |
